Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

VHIR becomes partner of the Barcelona Global platform

The Institute will participate in several projects of this association whose mission is to attract and develop talent and foster economic activity in Barcelona.

News

Research in rare diseases at VHIR

Catalan patient associations have recognized the Rare Diseases Unit of Vall d'Hebron, led by Dr. Eduardo Tizzano.

News

Josep Roca, the protagonist of the series of interviews of the Vall d'Hebron's 60th anniversary

Josep Roca, the protagonist of the series of interviews of the Vall d'Hebron's 60th anniversary

News

Extraordinary Prize on Neurosciencies for a VHIR’s researcher in Parkinson’s disease

Extraordinary Prize on Neurosciencies for a VHIR’s researcher in Parkinson’s disease

News

Dr. Marc Ribó presents an app for stroke patients at the Mobile World Congress

Dr. Marc Ribó, member of the Neurovascular Diseases group at Vall d'Hebron Institute of Research (VHIR) and neurologist of the Stroke Unite at Vall d'Hebron University Hospital, comes back to the https://www.mobileworldcongress.com/" Mobile World Congress to present the latest advances of the http:

News

The second edition of a predoctoral programme for physicians enhances different facets of research

Centres of excellence in biomedical research in Barcelona offer five fellowships as part of the new edition of the predoctoral programme in biomedicine for physicians, PhD4MD.

News

L'empresa Netquest ofereix la possibilitat de ser solidari amb la recerca en immunodeficiències al VHIR

La plataforma Worldcoo ha vehiculat aquesta iniciativa solidària que té l'objectiu de recaptar 7.000 euros.

News

VHIR opens the pre-enrolment for the 3rd edition of the Master’s Degree in Biomedical Translational Research

12 students from the first edition are currently working as researchers at the Institute.

News

Leo Messi supports cancer research in childhood and adolescence in Vall d'Hebron

Messi Foundation has funded the salary of a management of patient data from clinical trials in the Group of Translational Research in Childhood and Adolescent Cancer of VHIR.

News

The ‘Acuna Patata’ association raises 19,000 euros for research in neuroblastoma

The family of Dania, a 6 year-old patient treated of child cancer at Vall d'Hebron, have donated the check to the Translational Research in Child and Adolescent Cancer.

News

Vote for Dr. Joan Seoane as a candidate for the 'Vanguardia de la Ciencia' award

VHIO's researcher has been nominated for the discovery 'lumbar puncture against brain tumours', in which also participated researchers from VHIR

News

Cancer research at VHIR

Coinciding with the World Cancer Day, we have prepared an interactive presentation about our research in oncology.

News

Dr Xavier de la Cruz leads a course on massive sequencing in biomedicine

The reseracher at VHIR, together with his team, has given the course in Madrid and Zaragoza, and will teach it at VHIR in the coming months.

News

VHIR researchers talk to the media about zika virus

Doctors Israel Molina and Diana Pou have been interviewed in several media to explain this disease that is affecting Central and South America.

News

VHIR will have a Business Advisory Board looking for new strategic opportunities

The Business Advisory Board will meet again in September to choose a President and deal with specific objectives.

News

Dr Rello has the highest h-index in critical care medicine in Spain

Dr Jordi Rello, head of the Clinical Research and Innovation in Pneumonia and Sepsis (CRIPS) at Vall d'Hebron Institute of Research (VHIR), is the researcher with the highest h-index in the field of critical care medicine in Spain, according to the http://indice-h.webcindario.com/" ranking publishe

News

VHIR hosts successful EATRIS combined platform meeting

The plenary discussions covered strategy and goals, ongoing platform activities in platform meetings, and served to assess the current state of the art in four emerging technology areas of relevance to translational research.

News

Dr Simó Schwartz Jr is appointed editor of the European Journal of Nanomedicine

Dr Simó Schwartz Jr, director of the CIBBIM-Nanomedicine at Vall d'Hebron Institute of Research (VHIR), has been appointed member of the editorial board of the http://www.degruyter.com/view/j/ejnm" European Journal of Nanomedicine. VHIR's researcher will review some of the manuscripts submitted to

News

New mechanism of antitumor action identified

A team of researchers from UAB, VHIR and Ability Pharmaceuticals describe a new pathway that might be use to design safer and more effective anti-tumour drugs.